Search

everythinglearnresearchcommunity

for

Search:↓

The nail matrix has a reduced immune response, protecting it from autoimmunity.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Visceral leishmaniasis can mimic rheumatoid arthritis symptoms, especially in immunocompromised patients.

Patients with Alopecia Areata have higher levels of certain inflammatory markers.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Vitiligo is now seen as a systemic disease with promising new treatments and may offer protection against some diseases.

Severe acne patients have higher inflammatory markers than healthy people.

Autoimmune hepatitis in children often affects girls and can be treated successfully with medication.

New technologies help better understand and treat inflammatory skin diseases.

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

The girl's condition improved with treatment, showing no new autoimmune diseases and hair regrowth.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

A rare case shows alopecia areata and ITP occurring together, needing more research.

Adenosine receptors could be promising targets for treating inflammatory skin diseases like psoriasis.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Autoimmune diseases like lupus, dermatomyositis, and scleroderma can cause hair loss and other hair problems, and treatments for these diseases might also affect hair.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

A patient with granuloma annulare experienced both isotopic and isomorphic responses, with skin lesions responding to steroids but relapsing after stopping treatment.

People with autoimmune skin diseases often have hearing problems and should get their hearing checked early.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.